Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $47,034 - $55,115
1,862 Added 13.29%
15,872 $444,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $156,194 - $179,361
-6,033 Reduced 30.1%
14,010 $388,000
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $15,364 - $19,956
588 Added 3.02%
20,043 $577,000
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $4,984 - $5,767
-138 Reduced 0.7%
19,455 $713,000
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $8.24 Million - $10.7 Million
-209,176 Reduced 91.44%
19,593 $799,000
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $130,761 - $170,694
3,132 Added 1.39%
228,769 $11.7 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $46,560 - $56,838
-1,064 Reduced 0.47%
225,637 $9.87 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $9.5 Million - $11.3 Million
-204,265 Reduced 47.4%
226,701 $11.9 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $1.08 Million - $1.33 Million
23,533 Added 5.78%
430,966 $22.3 Million
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $12.4 Million - $18.4 Million
299,828 Added 278.64%
407,433 $24.1 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $307,013 - $394,385
-7,822 Reduced 6.78%
107,605 $4.63 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $579,336 - $656,290
-16,133 Reduced 12.26%
115,427 $4.52 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $38,480 - $43,397
-1,149 Reduced 0.87%
131,560 $4.77 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $225,085 - $286,216
6,725 Added 5.34%
132,709 $4.89 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $678,878 - $796,479
-21,382 Reduced 14.51%
125,984 $4.62 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $349,663 - $424,192
-11,609 Reduced 7.3%
147,366 $4.82 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $6.26 Million - $8.94 Million
-231,428 Reduced 59.28%
158,975 $5.19 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $22,253 - $25,255
-676 Reduced 0.17%
390,403 $15.3 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $5.12 Million - $6.64 Million
-157,705 Reduced 28.74%
391,079 $14.1 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $3.49 Million - $3.92 Million
94,460 Added 20.79%
548,784 $23.8 Million
Q1 2019

May 20, 2019

SELL
$37.5 - $41.2 $97,837 - $107,490
-2,609 Reduced 0.57%
454,324 $19.3 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $17.3 Million - $19.7 Million
449,561 Added 6098.22%
456,933 $19.9 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $9,582 - $11,623
-278 Reduced 3.63%
7,372 $325,000
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $61,342 - $65,397
1,860 Added 32.12%
7,650 $278,000
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $1,404 - $1,628
44 Added 0.77%
5,790 $205,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $191,111 - $202,776
5,746
5,746 $208,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.